StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.50−0.28 (-10.07%)

Close on Nov 18, 2026Market cap $23.40MP/E –Yield –

Adicet Bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Adicet Bio

Adicet Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Adicet Bio figures

See a number that looks wrong?